Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection
Status:
Recruiting
Trial end date:
2021-06-30
Target enrollment:
Participant gender:
Summary
The traditional Chinese herbal medicine Triptolide Wilfordii has displayed remarkable effect
on the treatment of autoimmune diseases such as rheumatoid arthritis. Now that
immunosuppression therapy has recently become a new strategy for HIV infection, it's
reasonable to expect the anti-inflammatory effect of Triptolide Wilfordii in HIV infected
patients. So we designed a randomized, double-blinded, placebo-controlled study to explore
the efficacy and safety of Triptolide Wilfordii in new-onset HIV infection.